February 7, 2018 / 7:24 AM / 5 months ago

BRIEF-Synairgen Says Patients Been Dosed In Phase II Trial Of Inhaled Sng001

Feb 7 (Reuters) - Synairgen Plc:

* ‍FIRST PATIENTS BEEN DOSED IN COMPANY’S PHASE II TRIAL OF INHALED SNG001 IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below